We are live on ! Find out more
PAWC

P.A.W. Capital Portfolio holdings

AUM $131M
1-Year Est. Return 46.14%
This Fund
S&P 500
This Quarter Est. Return
+55.79%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$93.8M
AUM Growth
+$13.6M
Cap. Flow
-$4.61M
Cap. Flow %
-4.92%
Top 10 Hldgs %
41.34%
Holding
68
New
7
Increased
10
Reduced
25
Closed
7

Top Buys

Rank Stock Value
1
OPRX icon
OptimizeRx
OPRX
+$2.78M
2
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$851K
3
SYRE icon
Spyre Therapeutics
SYRE
+$785K
4
SIX
Six Flags Entertainment Corp.
SIX
+$736K
5
WFC icon
Wells Fargo
WFC
+$629K

Top Sells

Rank Stock Value
1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$1.44M
2
MNDT
Mandiant, Inc. Common Stock
MNDT
+$1.2M
3
RGNX icon
Regenxbio
RGNX
+$1.19M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$1.12M
5
EVER icon
EverQuote
EVER
+$780K

Sector Composition

Rank Sector Weight
1 Technology 28.13%
2 Healthcare 25.68%
3 Communication Services 15.38%
4 Consumer Staples 9.73%
5 Financials 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
51
Procter & Gamble
PG
$340B
$625K 0.67%
5,000
– –
MS icon
52
Morgan Stanley
MS
$319B
$613K 0.65%
12,000
-3,000
-20% -$142K
GLMD icon
53
Galmed Pharmaceuticals
GLMD
$4.62M
$578K 0.62%
556
+167
+43% +$143K
IMDX
54
Insight Molecular Diagnostics
IMDX
$141M
$563K 0.6%
+12,500
New +$451K
TCPC icon
55
BlackRock TCP Capital
TCPC
$278M
$562K 0.6%
40,000
-10,000
-20% -$140K
KO icon
56
Coca-Cola
KO
$383B
$554K 0.59%
10,000
-2,000
-17% -$108K
NMFC icon
57
New Mountain Finance
NMFC
$654M
$550K 0.59%
40,000
+10,000
+33% +$135K
DD icon
58
DuPont de Nemours
DD
$18.6B
$514K 0.55%
+6,373
New +$529K
BX icon
59
Blackstone
BX
$104B
$503K 0.54%
9,000
-3,500
-28% -$182K
XOM icon
60
ExxonMobil
XOM
$650B
$488K 0.52%
7,000
-2,000
-22% -$138K
WY icon
61
Weyerhaeuser
WY
$17.6B
$453K 0.48%
15,000
-10,000
-40% -$290K
APYX icon
62
Apyx Medical
APYX
$162M
– –
-100,000
Closed -$677K
OHI icon
63
Omega Healthcare
OHI
$15.3B
– –
-12,000
Closed -$501K
TTE icon
64
TotalEnergies
TTE
$193B
– –
-10,000
Closed -$520K
CSSEP
65
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Series A Cumulative Redeemable Perpetual Preferred Stock
CSSEP
– –
-29,800
Closed -$715K
RETA
66
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-14,000
Closed -$1.12M
MNDT
67
DELISTED
Mandiant, Inc. Common Stock
MNDT
– –
-90,000
Closed -$1.2M
1 2
3

Similar funds

EIM
Emmett Investment Management New York $131M AUM 25.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
LC
LTG Capital Newton, Massachusetts $131M AUM 19.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
OIM
Oder Investment Management Woodland Hills, California $130M AUM 25.54% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $130M AUM

P.A.W. Capital's Q4 2019 Portfolio in Review

As of Q4 2019, P.A.W. Capital held 68 positions worth $93.8M, up 17% from $80.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

P.A.W. Capital withdrew a net $4.61M in Q4 2019, closing 7 positions and reducing 25 holdings. Its most notable exit was Mandiant, Inc. Common Stock, an estimated $1.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 34% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, P.A.W. Capital opened a new position in Orchard Therapeutics plc American Depositary Shares worth $963K.

  • P.A.W. Capital's largest Q4 2019 buy was Orchard Therapeutics plc American Depositary Shares: 7,000 shares worth $963K.
  • P.A.W. Capital added most to OptimizeRx in Q4 2019, an estimated $2.78M increase.
  • P.A.W. Capital's biggest Q4 2019 reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $1.44M.
  • P.A.W. Capital fully exited Mandiant, Inc. Common Stock in Q4 2019, selling an estimated $1.2M.
  • P.A.W. Capital's ten largest holdings make up 41% of its $93.8M portfolio in Q4 2019.
  • P.A.W. Capital opened 7 new positions and closed 7 in Q4 2019.
  • P.A.W. Capital's portfolio value rose 17% quarter-over-quarter to $93.8M.

Based on P.A.W. Capital's 13F filing for Q4 2019, filed 28 Jan 2020.